Companies

Inovio Pharmaceuticals Inc

NASDAQ: INO
$1.43
▼ $0.03 (−2.05%) today
Markets closed · 12:50pm ET

About Inovio Pharmaceuticals

INOVIO is a commercial-stage biotechnology company that develops DNA medicines to treat and protect against HPV-related diseases, cancer and infectious diseases. Its platform has two parts: proprietary plasmid DNA designs, which are small circular DNA molecules that instruct the body's cells to produce specific disease-fighting proteins, and its CELLECTRA electroporation delivery devices. These devices deliver the DNA without chemical adjuvants, lipid nanoparticles or viral vectors. The company's first commercial product, VOCERYQ, received FDA accelerated approval in October 2026 to reduce the frequency of surgery in adults with Recurrent Respiratory Papillomatosis (RRP). RRP is a rare HPV-6/11-driven disease, and INOVIO estimates at least 25,000 prevalent patients in the U.S. VOCERYQ is administered with the CELLECTRA 5PSP device over a 9-week regimen and holds FDA Orphan Drug and Breakthrough Therapy designations plus EU Orphan Drug designation. Commercial launch is planned for Q1 2027, supported by Syneos Health for field team deployment. INOVIO also generates modest revenue from collaborative arrangements. It is seeking partners for its next-generation DNA-Encoded Protein (DPROT) programs targeting rare diseases such as Hemophilia A, Fabry Disease and hypophosphatasia. Updated

INO Coverage

11:32am ET
Health and Healthcare

Why This Capital Injection Is Huge for Inovio

Inovio Pharmaceuticals has announced that it received $71 million in funding from the U.S. Department of Defense to support the production of its delivery device for the COVID-19 vaccine.

INO
Chris Lange
10:11am ET
Health and Healthcare

How Coronavirus Stocks Are Holding Up

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.

Chris Lange

Frequently Asked Questions

What does Inovio Pharmaceuticals do?

INOVIO is a commercial-stage biotechnology company that develops DNA medicines to treat and protect against HPV-related diseases, cancer and infectious diseases.